Xilio Therapeutics XLO SEC Filings

NASDAQ XLO
$8.47 -0.06 (-0.70%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Xilio Therapeutics, Inc. (XLO) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
1S-8Prospectus0001193125-26-454457Nov 10, 2026 7:45 AM-
210-QQuarterly & Annual Report0001193125-26-454453Nov 10, 2026 7:40 AM-
38-KCurrent Report0001193125-26-454449Nov 10, 2026 7:35 AM-
44Insider Transaction0001193125-26-412466Oct 2, 2026 12:33 AM
53Insider Transaction0001193125-26-412453Oct 2, 2026 12:31 AM
6SCHEDULE 13GBeneficial Ownership Report0001104659-26-096755Aug 14, 2026 4:01 PM
7S-8Prospectus0001193125-26-345762Aug 12, 2026 11:45 AM
810-QQuarterly & Annual Report0001193125-26-345759Aug 12, 2026 11:40 AM
98-KCurrent Report0001193125-26-345753Aug 12, 2026 11:35 AM
104Insider Transaction0001193125-26-269399Jun 12, 2026 8:07 PM
114Insider Transaction0001193125-26-269400Jun 12, 2026 8:07 PM
124Insider Transaction0001193125-26-269401Jun 12, 2026 8:07 PM
134Insider Transaction0001193125-26-269398Jun 12, 2026 8:07 PM
144Insider Transaction0001193125-26-269397Jun 12, 2026 8:07 PM
154Insider Transaction0001193125-26-269396Jun 12, 2026 8:07 PM
164Insider Transaction0001193125-26-269395Jun 12, 2026 8:07 PM
178-KCurrent Report0001193125-26-269358Jun 12, 2026 8:05 PM
18EFFECTOthers9999999995-26-001811May 29, 2026 4:15 AM
19CORRESPOthers0001193125-26-242232May 27, 2026 9:36 PM
20S-3Prospectus0001193125-26-242204May 27, 2026 9:30 PM
21UPLOADOthers0000000000-26-005065May 18, 2026 3:30 PM
22SCHEDULE 13GBeneficial Ownership Report0000947871-26-000552May 15, 2026 8:38 PM
23SCHEDULE 13GBeneficial Ownership Report0001193125-26-226925May 15, 2026 8:30 PM
24SCHEDULE 13GBeneficial Ownership Report0000919574-26-003488May 15, 2026 8:24 PM
25SCHEDULE 13GBeneficial Ownership Report0000919574-26-003213May 15, 2026 12:06 PM
26S-3Prospectus0001193125-26-218212May 12, 2026 11:48 AM
2710-QQuarterly & Annual Report0001193125-26-218200May 12, 2026 11:40 AM
288-KCurrent Report0001193125-26-218194May 12, 2026 11:35 AM
29ARSOthers0001193125-26-187691Apr 28, 2026 9:07 PM
30DEF 14AOthers0001193125-26-187642Apr 28, 2026 9:02 PM
314Insider Transaction0001193125-26-159316Apr 16, 2026 9:12 PM
323Insider Transaction0001193125-26-159314Apr 16, 2026 9:11 PM
338-KCurrent Report0001193125-26-157940Apr 16, 2026 11:35 AM
344Insider Transaction0001193125-26-131745Mar 30, 2026 9:29 PM
35S-8Prospectus0001193125-26-118559Mar 23, 2026 11:47 AM
3610-KQuarterly & Annual Report0001193125-26-118550Mar 23, 2026 11:40 AM
378-KCurrent Report0001193125-26-118544Mar 23, 2026 11:33 AM
388-KCurrent Report0001193125-26-103150Mar 12, 2026 12:34 PM
398-KCurrent Report0001193125-26-097603Mar 9, 2026 12:00 PM
408-KCurrent Report0001193125-26-065234Feb 24, 2026 12:30 PM
414Insider Transaction0001123292-26-000187Feb 17, 2026 10:31 PM
42SCHEDULE 13GBeneficial Ownership Report0001193125-26-054804Feb 17, 2026 9:30 PM
43SCHEDULE 13GBeneficial Ownership Report0001104659-26-015985Feb 17, 2026 3:00 PM
44SCHEDULE 13GBeneficial Ownership Report0001231919-26-000149Feb 13, 2026 10:31 PM
458-KCurrent Report0001193125-26-048942Feb 12, 2026 9:51 PM
46424B5Prospectus0001193125-26-048934Feb 12, 2026 9:49 PM
47SCHEDULE 13GBeneficial Ownership Report0001123292-26-000166Feb 12, 2026 9:39 PM
48424B5Prospectus0001193125-26-046842Feb 11, 2026 10:16 PM
49DEF 14AOthers0001193125-26-021691Jan 26, 2026 12:30 PM
50PRE 14AOthers0001193125-26-015343Jan 16, 2026 9:05 PM
...

Xilio Therapeutics, Inc. SEC Filings API

Pull Xilio Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=XLO&formtype=10-K,10-Q&api_key=YOUR_API_KEY